Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Disease area: Airway diseases, Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Trapnell (Cincinnati, United States of America), C. Ganslandt (Austin, United States of America), I. Tarnow (Austin, United States of America), T. Jouhikainen (Austin, United States of America), G. Waterer (Perth, Australia), C. Morgan (London, United Kingdom). Clinical features of autoimmune pulmonary alveolar proteinosis from a large international patient cohort: baseline data from the IMPALA trial. 5328

Member's Comments

No comment yet.

Related content which might interest you: Baseline characteristics of an Italian cohort of pulmonary alveolar proteinosis (PAP) patients Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Clinical assessment and management of pulmonary alveolar proteinosis: the importance of a reference centre Source: Annual Congress 2009 - Pulmonary alveolar proteinosis: clearing the Milky Way Year: 2009 Baseline characteristics of the Italian cohort of patients affected by pulmonary alveolar proteinosis (PAP) Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Outcomes of patients with progressive fibrosing interstitial lung disease (PF-ILD) – data from a prospective ILD registry Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting Source: International Congress 2014 – ILDs 6 Year: 2014 Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Cross-sectional and longitudinal measurement of autoantibody levels against GM-CSF is useful for predicting clinical courses of in autoimmune pulmonary alveolar proteinosis. Source: International Congress 2017 – Rare diseases Year: 2017 Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials Source: Eur Respir J 2016; 47: 243-253 Year: 2016 Diagnostic value of radiographic findings with literature review in Chinese pulmonary alveolar proteinosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 744s Year: 2006 STARMAP: an observational study to assess disease-relevant outcomes using home-monitoring devices in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Home oxygen saturation monitoring and quality of life in patients with idiopathic pulmonary fibrosis: A prospective multicenter trial Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan Source: Eur Respir J 2011; 37: 465 Year: 2011 Healthy survivor bias in patients with idiopathic pulmonary fibrosis in clinical registries. Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Autoimmune pulmonary alveolar proteinosis complicated with infections: a nationwide surveillance study in Japan Source: International Congress 2017 – Rare diseases Year: 2017 Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018 Year: 2019